News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Senopsys and Patheon (PTI.TO) Collaborate to Develop Palatable Drug Products


6/19/2007 1:00:59 PM

SAUGUS, Mass.--(BUSINESS WIRE)--Senopsys LLC, a specialty pharmaceutical services company, announced today that it has signed a collaboration agreement with Patheon Inc. (TSX:PTI), a leading global provider of drug development and manufacturing services, to accelerate the development of palatable drug products. Through this collaboration, Senopsys clients will have access to prototype drug formulations manufactured by Patheon and Patheon will be able to offer its clients taste assessment and optimization services.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES